MX2014007437A - Procedimiento de deteccion de una infeccion por el virus de la hepatitis c. - Google Patents

Procedimiento de deteccion de una infeccion por el virus de la hepatitis c.

Info

Publication number
MX2014007437A
MX2014007437A MX2014007437A MX2014007437A MX2014007437A MX 2014007437 A MX2014007437 A MX 2014007437A MX 2014007437 A MX2014007437 A MX 2014007437A MX 2014007437 A MX2014007437 A MX 2014007437A MX 2014007437 A MX2014007437 A MX 2014007437A
Authority
MX
Mexico
Prior art keywords
capsid
hepatitis
virus
infection
peptide
Prior art date
Application number
MX2014007437A
Other languages
English (en)
Other versions
MX365962B (es
Inventor
Stéphane Gadelle
François Rieunier
Original Assignee
Bio Rad Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Innovations filed Critical Bio Rad Innovations
Publication of MX2014007437A publication Critical patent/MX2014007437A/es
Publication of MX365962B publication Critical patent/MX365962B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/186—Hepatitis C; Hepatitis NANB
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a un procedimiento de detección in vitro de una infección por un virus de la hepatitis C (VHC) en una muestra biológica, que comprende la detección simultánea de la proteína de cápside de VHC, y de un anticuerpo dirigido contra la citada proteína de cápside, que este procedimiento utiliza, para capturar los anticuerpos anticápside, que un péptido comprende un fragmento antigénico derivado de la cápside de VHC truncada. La invención se refiere también al péptido para capturar los anticuerpos anticápside y los kits que los comprenden.
MX2014007437A 2011-12-20 2012-12-19 Procedimiento de detección de una infección por el virus de la hepatitis c. MX365962B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1161981A FR2984328B1 (fr) 2011-12-20 2011-12-20 Procede de detection d'une infection par le virus de l'hepatite c
PCT/FR2012/053001 WO2013093345A1 (fr) 2011-12-20 2012-12-19 Procede de detection d'une infection par le virus de l'hepatite c

Publications (2)

Publication Number Publication Date
MX2014007437A true MX2014007437A (es) 2015-03-03
MX365962B MX365962B (es) 2018-05-04

Family

ID=47599082

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007437A MX365962B (es) 2011-12-20 2012-12-19 Procedimiento de detección de una infección por el virus de la hepatitis c.

Country Status (12)

Country Link
US (2) US9719994B2 (es)
EP (1) EP2794638B1 (es)
JP (1) JP6312600B2 (es)
CN (1) CN104302660B (es)
AR (1) AR089335A1 (es)
AU (1) AU2012356512B2 (es)
BR (1) BR112014015201A2 (es)
CA (1) CA2859736C (es)
FR (1) FR2984328B1 (es)
MX (1) MX365962B (es)
TW (1) TW201337268A (es)
WO (1) WO2013093345A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒
WO2021254476A1 (zh) * 2020-06-19 2021-12-23 南京金斯瑞生物科技有限公司 检测SARS-CoV-2病毒中和抗体的磁微粒化学发光试剂盒及其应用
WO2023207918A1 (en) * 2022-04-25 2023-11-02 Beijing Hanmoluojie Technology Co., Ltd. Aav capsid 3d molecular surface feature mapping

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693489A (en) 1984-03-30 1997-12-02 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5683864A (en) 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6027729A (en) 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
WO1991015771A1 (en) 1990-04-04 1991-10-17 Chiron Corporation Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
DE69232871T2 (de) 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
DE69232859T2 (de) 1991-09-13 2003-04-10 Chiron Corp Zusammensetzung aus mehreren immunreaktiven hepatitis-c-virus-polypeptiden
SG77551A1 (en) 1992-03-06 2005-04-28 Innogenetics Nv Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing
FR2690921B1 (fr) 1992-05-06 1995-06-30 Bio Merieux Polypeptides de synthese appartenant au virus de l'hepatite c (vhc) et utilisables notamment pour detecter ce dernier.
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
ATE281647T1 (de) 1993-05-10 2004-11-15 Chiron Corp Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
CA2162557C (en) 1993-05-12 2004-09-28 Amy J. Weiner Conserved motif of hepatitis c virus e2/ns1 region
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
EP0773957B1 (en) 1994-07-29 2005-06-29 Chiron Corporation Secreted hepatitis C virus E1/E2 complex obtained from C-terminally truncated E1 and E2 polypeptides
DE4428705A1 (de) 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
EP0752102B1 (fr) 1995-01-23 2000-11-15 Pasteur Sanofi Diagnostics Conjugue immunoenzymatique, son procede de preparation et ses applications
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
JP3715027B2 (ja) 1996-05-07 2005-11-09 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬
EP0870830A3 (en) 1997-02-10 2004-02-25 Advanced Life Science Institute, Inc. Chimera hepatitis C virus antigen
CA2607990C (en) 1997-08-04 2009-09-22 Advanced Life Science Institute, Inc. Methods for detecting or assaying virus
CA2493240A1 (en) 1997-08-04 1999-02-11 Advanced Life Science Institute, Inc. Methods for detecting or assaying virus
EP1801591B1 (en) 1997-08-04 2016-12-28 Advanced Life Science Institute, Inc. Methods for detection or measurement of viruses
DK1471074T3 (da) 1998-04-17 2008-11-17 Innogenetics Nv Fremgangsmåder til forbedring af konformationen af proteiner ved hjælp af reduktionsmidler
US6623921B2 (en) 1998-07-30 2003-09-23 Advanced Life Science Institute, Inc. Method for measurement of hepatitis C virus
DE69939811D1 (de) 1998-07-30 2008-12-11 Advanced Life Science Inst Inc Verfahren zur bestimmung von hepatitis c viren
EP1131345A1 (en) * 1998-11-20 2001-09-12 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
ES2279766T3 (es) 1999-07-28 2007-09-01 Novartis Vaccines And Diagnostics, Inc. Sistemas de deteccion por inmunoensayos del antigeno viral de hepatitis c.
ATE368221T1 (de) 2000-06-15 2007-08-15 Novartis Vaccines & Diagnostic Immunoassays für anti-hcv-antikörper
AR033448A1 (es) 2001-03-28 2003-12-17 Ortho Clinical Diagnostics Inc Prueba de combinacion antigeno-anticuerpo para hepatitis c para una deteccion temprana de la infeccion
JP4353793B2 (ja) 2001-06-26 2009-10-28 アボット・ラボラトリーズ Ｈｃｖ抗原とｈｃｖ抗体との同時検出のための方法
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
US7049060B2 (en) 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US20030108563A1 (en) * 2001-11-07 2003-06-12 Chander Bahl Reagents for the simultaneous detection of HCV core antigens and antibodies
US7332269B2 (en) 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
PL209710B1 (pl) 2002-09-09 2011-10-31 Chiron Corp Sposób wykrywania infekcji wirusem zapalenia wątroby typu C (HCV)
US8865398B2 (en) * 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
US20120046188A1 (en) * 2009-03-30 2012-02-23 bioMerieux, SA Solid Support for HCV Detection
US20100297607A1 (en) 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
CN102081018A (zh) 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法

Also Published As

Publication number Publication date
CA2859736C (fr) 2021-03-30
CN104302660A (zh) 2015-01-21
US20140335508A1 (en) 2014-11-13
AU2012356512B2 (en) 2017-07-20
AR089335A1 (es) 2014-08-13
WO2013093345A1 (fr) 2013-06-27
EP2794638B1 (fr) 2020-05-27
BR112014015201A2 (pt) 2019-09-24
FR2984328B1 (fr) 2016-12-30
US20170328905A1 (en) 2017-11-16
FR2984328A1 (fr) 2013-06-21
US10345305B2 (en) 2019-07-09
TW201337268A (zh) 2013-09-16
US9719994B2 (en) 2017-08-01
JP2015502552A (ja) 2015-01-22
CN104302660B (zh) 2018-04-20
AU2012356512A1 (en) 2014-07-24
JP6312600B2 (ja) 2018-04-18
MX365962B (es) 2018-05-04
CA2859736A1 (fr) 2013-06-27
EP2794638A1 (fr) 2014-10-29

Similar Documents

Publication Publication Date Title
MX2019001767A (es) Anticuerpos monoclonales que se unen al dominio de union a lipidos de la proteina de la capside del virus de la hepatitis c (vhc).
WO2008027942A3 (en) Combination hepatitis c virus antigen and antibody detection method
EA201391170A1 (ru) Терапевтическое средство на основе дрожжей для лечения хронического гепатита b
SG11201810029PA (en) Immunochromatography Analysis Device for Detecting Zika Virus
EA201492110A1 (ru) Вакцины против впг-2
MX2009005942A (es) Anticuerpos recombinantes contra el virus de hepatitis c y metodos para obtener y usar los mismos.
WO2014134561A3 (en) Quantification of vaccine compositions
CL2013003248A1 (es) Composición inmunogenica que comprende una glucoproteina g de los virus hendra y nipah y un complejo inmunoestimulante; método para producir una respuesta de anticuerpo neutralizante contra un virus hendra y/o nipah en un sujeto.
WO2015095355A3 (en) Detection of an antibody against a pathogen
EA201390806A1 (ru) Конструкция пептидного каркаса
EP2641914A4 (en) MONOCLONAL ANTIBODY FOR THE RECOGNITION OF HUMAN PAPILLOMA (HPV) PROTEIN L2 AND METHOD FOR MEASURING HPV NEUTRALIZING ANTIBODIES THEREWITH
MX2015012824A (es) Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
MX2014011504A (es) Metodos para la deteccion de anticuerpos neutralizantes anticitomegalovirus.
WO2013165972A3 (en) Anti-hepatitis b virus antibodies and use thereof
WO2009035412A8 (en) Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof
EA201071086A1 (ru) Усовершенствованный способ получения вакцинных антигенов вируса гриппа
MX2016005686A (es) Ensayo de union competitiva al ligando para detectar anticuerpos neutralizantes.
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
MX365962B (es) Procedimiento de detección de una infección por el virus de la hepatitis c.
EA202191931A1 (ru) Способ характеризации видимых и/или невидимых частиц в биологических препаратах
WO2015196192A3 (en) Methods and compositions relating to dengue virus
EA201400216A1 (ru) Консервирование биологических продуктов, в частности вакцин, с применением вакуума
WO2007108568A8 (en) Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope
EP3805251A4 (en) METHOD FOR EFFICIENT INDUCTION OF ANTIBODIES TO HEPATITIS VIRUS, ANTIBODIES AND DETECTION SYSTEM
EA201991843A1 (ru) Способ иммунологического определения специфических антител к антигенам вирусов семейства поксвирусов

Legal Events

Date Code Title Description
FG Grant or registration